Mid-term and long-term efficacy and effectiveness of antipsychotic medications for schizophrenia: a data-driven, personalized clinical approach.
about
Current Data on and Clinical Insights into the Treatment of First Episode Nonaffective Psychosis: A Comprehensive ReviewRecent advances in understanding schizophreniaWorld Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects.Quantifying clinical relevance in the treatment of schizophrenia.Recommendations for the optimal care of patients with recent-onset psychosis in the Asia-Pacific region.Recent advances in understanding and mitigating adipogenic and metabolic effects of antipsychotic drugs.The personal, societal, and economic burden of schizophrenia in the People's Republic of China: implications for antipsychotic therapy.Drug treatment developments in schizophrenia and bipolar mania: latest evidence and clinical usefulness.Optimizing outcomes in schizophrenia: long-acting depots and long-term treatment.Systematic Literature Review of the Methods Used to Compare Newer Second-Generation Agents for the Management of Schizophrenia: A focus on Health Technology Assessment.Discontinuation of clozapine: a 15-year naturalistic retrospective study of 320 patients.Haloperidol versus second-generation antipsychotics in the long-term treatment of schizophrenia.Insight and recovery in schizophrenic patients.
P2860
Q28079821-85A9AF89-4AD7-4584-9257-9D83B3AA46CBQ33942094-39A80944-749E-47A5-81E5-FB33FCC89647Q34315836-DFEDF5DD-C5F0-46DA-9450-FEB40C1F661BQ35819467-1A73C2D5-BC87-41EB-9640-0E8056E6A585Q35984960-71B83FB7-D68E-4278-8BCA-B7C5A4E0A3BFQ36063735-64CFE0FF-8055-4EFB-AD89-E4BAD1A02866Q37111828-271C2386-5874-4FFC-B840-B9C651DDFF91Q38076126-D2CCF79B-E5ED-4775-8868-7958626E369DQ38086645-E89D5765-7883-487C-95F2-BD6EE2D15D01Q38473914-C7319AC5-A199-4DEF-BF8B-E40523FE4890Q39302471-B4F6ABC0-E3B6-4F25-B0B5-4E525BCF5668Q48679684-AEA223AF-B18C-4403-931E-4AD2C82CEFA2Q50230040-67BF819A-51C7-4705-AC08-610DC6DB8393
P2860
Mid-term and long-term efficacy and effectiveness of antipsychotic medications for schizophrenia: a data-driven, personalized clinical approach.
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Mid-term and long-term efficac ...... ersonalized clinical approach.
@ast
Mid-term and long-term efficac ...... ersonalized clinical approach.
@en
Mid-term and long-term efficac ...... ersonalized clinical approach.
@nl
type
label
Mid-term and long-term efficac ...... ersonalized clinical approach.
@ast
Mid-term and long-term efficac ...... ersonalized clinical approach.
@en
Mid-term and long-term efficac ...... ersonalized clinical approach.
@nl
prefLabel
Mid-term and long-term efficac ...... ersonalized clinical approach.
@ast
Mid-term and long-term efficac ...... ersonalized clinical approach.
@en
Mid-term and long-term efficac ...... ersonalized clinical approach.
@nl
P2093
P356
P1476
Mid-term and long-term efficac ...... ersonalized clinical approach.
@en
P2093
A Carlo Altamura
Christoph U Correll
Ira D Glick
John G Csernansky
John M Davis
Peter J Weiden
Stefan Leucht
Stephen R Marder
P304
P356
10.4088/JCP.11R06927
P577
2011-12-01T00:00:00Z